首页/数据集/Policies for biosimilars in different countries in Europe (April 2017).

Policies for biosimilars in different countries in Europe (April 2017).

NIAID Data Ecosystem2026-03-10 收录

数据链接：

https://figshare.com/articles/dataset/Policies_for_biosimilars_in_different_countries_in_Europe_April_2017_/5741355 数据链接链接失效反馈

官方服务：

资源简介：

Policies for biosimilars in different countries in Europe (April 2017).

应用场景：

创建时间：

2017-12-29

生物类似药

医疗政策优化

Biologic medicines have transformed treatment for numerous chronic and life-threatening conditions such as cancer and diabetes. These therapies can offer significant benefits in efficacy for specific

Organisation for Economic Co-operation and Development90

Statistical Considerations in Demonstrating CMC Analytical Similarity for a Biosimilar Product

生物类似药

统计分析

Demonstration of analytical similarity between a reference product and a biosimilar product is required as part of the biosimilarity approval process. A statistical two one-sided test (TOST) based on

DataCite Commons2020-09-02 更新60

Statistical Considerations in Demonstrating CMC Analytical Similarity for a Biosimilar Product

生物类似药

统计分析

Demonstration of analytical similarity between a reference product and a biosimilar product is required as part of the biosimilarity approval process. A statistical two one-sided test (TOST) based on

DataCite Commons2020-09-02 更新50

Statistical Considerations in Demonstrating CMC Analytical Similarity for a Biosimilar Product

生物类似药

统计分析

Demonstration of analytical similarity between a reference product and a biosimilar product is required as part of the biosimilarity approval process. A statistical two one-sided test (TOST) based on

DataCite Commons2020-09-02 更新70

生物类似药

生物制药

Eporatio, biosimilar epoetin theta (ratioepo, epoetin theta) - BioCentury Product Profiles for the biopharma industry

profiles.biocentury.com60